As bars and restaurants across the globe contemplate how to safely serve diners during the pandemic, many establishments are seeking ways to reduce the number of touchpoints between servers and guests ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
BBO-8520 monotherapy in patients with KRAS G12C non-small cell lung cancer (NSCLC) showed a 65% objective response rate (ORR) and a 66% 6-month progression-free survival (PFS), with 83% of patients ...
Bbot Inc. a restaurant and hospitality tech startup focused on simplifying and improving the ordering and payment process, announced the closing of a $4 million seed extension funding round. Rally ...
BBOT debuted as a publicly traded oncology company developing a differentiated portfolio of three clinical-stage small molecule inhibitors targeting the RAS pathway. Announced encouraging preliminary ...
Bbot, the hospitality tech provider that focuses on digital ordering and payments for restaurants, has agreed to be acquired by DoorDash to expand its service offering to merchants. The terms of the ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
DoorDash is acquiring Bbot, a hospitality technology startup. The acquisition will offer merchants more solutions for their in-store and online channels, including in-store digital ordering and ...
Steve Simoni wasn't planning on starting a software company. Instead, he and his colleagues were intent on building a robot that would make it easier for them to get drinks at a bar. Their original ...
We recently compiled a list of the 10 Most Promising Cancer Stocks According to Wall Street Analysts. BridgeBio Oncology ...
Pedro J. Beltran, PhD, a seasoned executive who previously served as Chief Scientific Officer of BBOT, will assume the position of Chief Executive Officer, bringing his extensive drug development ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results